Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVAXIN in Healthy Children and Adolescents
NCT04918797Phase 3Completed
- Sponsor
- Bharat Biotech
- Start
- May 2021
- Primary completion
- Aug 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of COVAXIN in coronavirus disease 2019 (COVID-19), sponsored by Bharat Biotech. Started May 2021; status: completed.
02
Drugs
COVAXIN
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04918797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918797.